# Correction: Molecular resistance mechanisms to newly approved antibiotics (2017–2025) in WHO priority pathogens

PMC · DOI: 10.3389/fmicb.2026.1793977 · Frontiers in Microbiology · 2026-02-13

## Full-text entities

- **Genes:** AmpC [NCBI Gene 7872529]
- **Diseases:** cUTIs (MESH:D000092182)
- **Chemicals:** Delafloxacin (MESH:C477891), Plazomicin (MESH:C550938), Omadacycline (MESH:C000591640), iron (MESH:D007501), Cefepime (MESH:D000077723), Meropenem (MESH:D000077731), fluoroquinolones (MESH:D024841), Quinolones (MESH:D015363), Rifamycin (MESH:D012294), enmetazobactam (MESH:C000656730), Eravacycline (MESH:C571179), Aztreonam-avibactam (-), vaborbactam (MESH:C000626994)
- **Species:** Klebsiella pneumoniae (species) [taxon 573], Escherichia coli (E. coli, species) [taxon 562], Acinetobacter baumannii (species) [taxon 470]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12947779/full.md

---
Source: https://tomesphere.com/paper/PMC12947779